Differentially expressed genes between normal placenta and choriocarcinoma by Xue, W et al.
Title Differentially expressed genes between normal placenta andchoriocarcinoma
Author(s) Feng, H; Xue, W; Cheung, A; Wang, YL; Tsao, GSW
Citation 43rd Annual Meeting of the American Society for Cell Biology,San Francisco, California, 13-17 December 2003, v. 14 n. Suppl
Issued Date 2003
URL http://hdl.handle.net/10722/53987
Rights Creative Commons: Attribution 3.0 Hong Kong License
Differentially Expressed Genes between Normal Placenta and Choriocarcinoma 
H. Feng,1 W. Xue,2 A. Cheung,2 Y. Wang,3 G. Tsao1 ; 1 Anatomy, Faculty of Medicine, University of Hong Kong, 
Hong Kong, Hong Kong Special Administrative Region of China, 2 Pathology, Faculty of Medicine, University of 
Hong Kong, Hong Kong, Hong Kong Special Administrative Region of China, 3 State Key Laboratory of 
Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China 
Presentation Number: 2774 
Poster Board Number: B505 
Gestational Trophoblastic Disease (GTD) refers to series of lesions originating from the placental trophoblasts, 
including hydatidiform mole, invasive mole, choriocarcinoma and placental site trophoblastic tumor. GTD is 
relatively more common in Asia and Africa. Choriocarcinoma is the most aggressively malignancy in GTD. The 
cancer cells can metastasize to lung, vagina, liver and brain. Little is known about the molecular mechanisms 
involved in the pathogenesis and/or progression of choriocarcinoma. To investigate the differentially expressed 
genes associated with choriocarcinoma, we use cDNA array to compare three cell lines, B6 cell line immortalized 
from normal placenta and another two choriocarcinoma cell lines, JAR and JEG-3. The result showed that in the 
expression level at least 27 genes were altered. Of theses genes, 5 genes were up-regulated and 22 genes were 
down-regulated in choriocarcinoma. TIMP3, PLAB and IGFBP3 were down-regulated and CCNB1 was up-
regulated in choriocarcinoma by real time PCR assay. Immunohistochemical staining with TIMP3 antibody also 
showed significantly low expression in clinical samples of choriocarcinoma. Methylation was found in 
choriocarcinoma cell lines and tumor tissues. TIMP3 expression can be restored by 5-aza-2’-deoxycytidine in 
choriocarcinoma cell lines. The reduced expression of TIMP3 in choriocarcinoma may thus be due to methylation. 
This study shows that TIMP3 maybe a potential candidate molecular maker for diagnosis and therapy of 
choriocarcinoma. 
